Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

May 21, 2014 17:29 ET | Source: Acasti Pharma Inc.

Acasti Announces Fourth Quarter and Fiscal Year Results

LAVAL, Quebec, May 21, 2014 (GLOBE NEWSWIRE) -- Acasti Pharma Inc. ("Acasti" or the "Corporation") (Nasdaq:ACST) (TSX-V:APO), an emerging biopharmaceutical company focused on the research, development...
May 01, 2014 08:29 ET | Source: Acasti Pharma Inc.

Acasti to Present at Two Scientific Forums

LAVAL, Quebec, May 1, 2014 (GLOBE NEWSWIRE) -- Acasti Pharma Inc. ("Acasti" or the "Corporation") (Nasdaq:ACST) (TSX-V:APO), an emerging biopharmaceutical company focused on the research, development...
February 14, 2014 09:40 ET | Source: Acasti Pharma Inc.

Acasti and Neptune Provide Update on Patent Litigations with Enzymotec

LAVAL, QUEBEC, Feb. 14, 2014 (GLOBE NEWSWIRE) -- Neptune Technologies & Bioressources Inc. ("Neptune") (Nasdaq:NEPT) (TSX:NTB) and Acasti Pharma Inc. ("Acasti") (Nasdaq:ACST) (TSX-V:APO), a...
February 07, 2014 08:00 ET | Source: Acasti Pharma Inc.

Acasti Announces Closing of CAD$2.15 Million Private Placement

LAVAL, Quebec, Feb. 7, 2014 (GLOBE NEWSWIRE) -- Acasti Pharma Inc. ("Acasti" or the "Corporation") (Nasdaq:ACST) (TSX-V:APO), an emerging biopharmaceutical company focused on the research, development...
January 14, 2014 07:30 ET | Source: Acasti Pharma Inc.

Acasti Announces Third Quarter Results

LAVAL, Quebec, Jan. 14, 2014 (GLOBE NEWSWIRE) -- Acasti Pharma ("Acasti" or the "Corporation") (Nasdaq:ACST) (TSX-V:APO), a Neptune Technologies & Bioressources Inc.'s ("Neptune") subsidiary,...
January 09, 2014 07:30 ET | Source: Acasti Pharma Inc.

FDA Clears Acasti's Investigational New Drug Submission to Conduct PK Trial

LAVAL, Quebec, Jan. 9, 2014 (GLOBE NEWSWIRE) -- Acasti Pharma Inc. ("Acasti" or the "Corporation") (Nasdaq:ACST) (TSX-V:APO), an emerging biopharmaceutical company, announces that the U.S. Food and...
December 19, 2013 07:30 ET | Source: Acasti Pharma Inc.

Acasti Appoints Jerald J. Wenker as Special Advisor and Nominee to Its Board of Directors

LAVAL, Quebec, Dec. 19, 2013 (GLOBE NEWSWIRE) -- Acasti Pharma Inc. ("Acasti" or the "Corporation") (Nasdaq:ACST) (TSX-V:APO), an emerging biopharmaceutical company focused on the research,...
December 18, 2013 08:58 ET | Source: Acasti Pharma Inc.

Neptune, Acasti and Enzymotec Sign Settlement Term Sheet Resulting in Stay of ITC Investigation for 30 Days

LAVAL, Quebec, Dec. 18, 2013 (GLOBE NEWSWIRE) -- Neptune Technologies & Bioressources Inc. ("Neptune") (Nasdaq:NEPT) (TSX:NTB) and Acasti Pharma Inc. ("Acasti") (Nasdaq:ACST) (TSX-V:APO), a...
December 17, 2013 08:30 ET | Source: Acasti Pharma Inc.

Neptune and Aker BioMarine Reach Patent Infringement Settlement and License Agreement

LAVAL, Quebec, Dec. 17, 2013 (GLOBE NEWSWIRE) -- Neptune Technologies & Bioressources Inc. ("Neptune") (Nasdaq:NEPT) (TSX:NTB), Acasti Pharma Inc. ("Acasti") (Nasdaq:ACST) (TSX-V:APO) a Neptune...
December 03, 2013 10:14 ET | Source: Acasti Pharma Inc.

Acasti Announces Closing of US$23 Million Underwritten Offering of Units

LAVAL, Quebec, Dec. 3, 2013 (GLOBE NEWSWIRE) -- Acasti Pharma Inc. ("Acasti" or the "Corporation") (Nasdaq:ACST) (TSX-V:APO), an emerging biopharmaceutical company focused on the research, development...